The American Association for Clinical Chemistry (AACC) unveiled Biomarkers of Cardiovascular Disease, a conference to be held October 1 and October 2, in Singapore. The conference is cosponsored by the Asian Pacific Federation of Clinical Biochemistry, Indonesian Heart Association, Japanese Atherosclerosis Society, Singapore Association of Clinical Biochemists, Singapore Cardiac Society, and the Taiwan Society of Cardiology, and is supported by Roche Diagnostics.
The conference is being held to complement a 2012 Special Issue on cardiovascular disease (CVD) from AACC’s flagship journal Clinical Chemistry. Designed to improve the global understanding of CVD, this conference, organized by Clinical Chemistry, assembles world leaders on the condition from Australia, Canada, Iceland, Norway, and the US. In addition to sessions dealing with Biomarkers in the Prevention of Cardiovascular Disease; Genomics, Proteomics, and Biomarkers of Cardiovascular Disease; and Biomarkers in the Diagnosis and Management of Cardiovascular Disease; participants will have the opportunity on the final afternoon to participate in three Independent Expert Panel discussions with conference speakers where they can contribute to the conference. Clinical Chemistry has also invited investigators to be a part of this international conference by submitting abstracts for the poster session. Abstracts are sought on all areas of CVD prevention, diagnosis, and management from both the clinical laboratory and the clinician’s perspective. A detailed program for the conference is available here.
Source: AACC
